EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Comparative Efficacy of Jaipur Block versus Modified Jaipur Block in the Management of Postherpetic Neuralgia: A Randomized Controlled Trial

Bhagwan Dass, Priya Jangid, Gautam Chand Sirvi, Puneet Bhargava

International Journal of Current Pharmaceutical Review and Research · 30.06.2026 · 18 (06)

DOI: 10.25258/ijcpr.18.6.183 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.06.2026. Verfasst von Bhagwan Dass und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Postherpetic neuralgia (PHN) is among the most refractory chronic pain syndromes encountered in clinical practice. Subcutaneous nerve block therapy offers a practical, cost-effective interventional option suitable for outpatient settings; however, no prospective randomized comparison between the dexamethasonebased Jaipur Block and the methylprednisolone-based Modified Jaipur Block has been published. The present study was undertaken to address this gap.

Methods

Eighty patients with PHN attending the outpatient department of a tertiary dermatology centre were randomly allocated into Group A (Jaipur Block, n=40) and Group B (Modified Jaipur Block, n=40). Subcutaneous injections were administered at the site of maximum pain within the affected dermatome at 6week intervals, for a maximum of three sessions over six months. Pain severity was assessed using the Visual Analogue Scale (VAS, 0–10 cm) at baseline and at each follow-up visit.

Results

Both interventions produced statistically significant reductions in VAS after each injection (p0.05). Disease duration under six months and age below 60 years were the strongest positive predictors of outcome.

Conclusion

Both blocks are effective in PHN. The original dexamethasone-based Jaipur Block is recommended as the preferred regimen, given its marginally superior complete-relief rate and better performance in elderly patients and those with ophthalmic dermatome involvement. Early initiation of therapy, ideally within six months of onset, is critical for optimal outcomes.

Zitieren

APA

Dass, B., Jangid, P., Sirvi, G. C., & Bhargava, P. (2026). Comparative Efficacy of Jaipur Block versus Modified Jaipur Block in the Management of Postherpetic Neuralgia: A Randomized Controlled Trial. International Journal of Current Pharmaceutical Review and Research, 18(06). https://doi.org/10.25258/ijcpr.18.6.183

Vancouver

Dass B, Jangid P, Sirvi GC, Bhargava P. Comparative Efficacy of Jaipur Block versus Modified Jaipur Block in the Management of Postherpetic Neuralgia: A Randomized Controlled Trial. International Journal of Current Pharmaceutical Review and Research. 2026;18(06). doi:10.25258/ijcpr.18.6.183

BibTeX
@article{Dass2026,
  author = {Dass, Bhagwan and Jangid, Priya and Sirvi, Gautam Chand and Bhargava, Puneet},
  title = {Comparative Efficacy of Jaipur Block versus Modified Jaipur Block in the Management of Postherpetic Neuralgia: A Randomized Controlled Trial},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {06},
  doi = {10.25258/ijcpr.18.6.183}
}
Kostenlos starten →